as reflected in the Director-Generals report,1WHA51.9= = = 21. URGES all Member States:(1) to review existing legislation, regulations, and guidelines to ensure that they are applicable andadequate to cover questions of advertising, promotion, and sale of medical products using the Internet andto develop, evaluate, and implement strategies for monitoring, surveillance and enforcement;(2) to collaborate in matters raised by use of the Internet, especially (a) the dissemination of informationon difficult cases, (b) the cross-border advertising, promotion, and sale of medical products using theInternet, and (c) specific national measures for enforcement; to designate contact points for suchcollaboration; and to disseminate this information through WHO;(3) to promote the use of the Internet for obtaining scientific information about medical products,validated by competent health authorities to ensure the quality of this information;2. APPEALS to industry, health professional and consumer organizations and other interested parties:(1) to encourage their members, where appropriate, to promote the formulation and use of goodinformation practices, where applicable consistent with the principles embodied in the WHO EthicalCriteria for Medicinal Drug Promotion;(2) to monitor and report problem cases and aspects of cross-border advertising, promotion, and sale ofmedical products using the Internet;(3) to maintain legal and ethical standards in the cross-border advertising, promotion, and sale of medicalproducts using the Internet;3. REQUESTS the Director-General:(1) to encourage the international community to formulate self-regulatory guidelines for goodinformational practices, consistent with the principles of the WHO Ethical Criteria for Medicinal DrugPromotion;(2) to develop a model guide for Member States to educate people using the Internet as to how best toobtain reliable, independent and compatible information on medical products using the Internet;(3) to collaborate with other appropriate international organizations and institutions on Internet issuesrelating to medical products;(4) to urge Member States to setup or strengthen mechanisms to monitor and survey cross-borderadvertising, promotion, and sale of medical products using the Internet, and provide technical assistanceas required;(5) to urge Member States to take regulatory action, where appropriate, against violation of their nationallaws regarding cross-border advertising, promotion, and sale of medical products using the Internet;(6) to encourage Member States and nongovernmental organizations concerned to report to WHOproblem cases and aspects of cross-border advertising, promotion, and sale of medical products using theInternet and report problem cases and other aspects, as appropriate.Tenth plenary meeting, 16 May 1998A51 / VR / 10